Logiscreen

ANI Pharmaceuticals Inc

$81.11
Market Cap 1.82B
ROE 17.9%
Gross Margin 60.6%
Debt/Equity 1.1
Current Ratio 3.1
Revenue QoQ 20.5%
EPS QoQ 0.9%
F-Score 8

About

ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Established Brands business.

Exchange
NASDAQ
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
19.43
vs median 33.61
P/B
3.16
vs median 2.16
ROE
0.18
vs median 0.09

High quality company with strong fundamentals

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics